We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn more.
We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn more.
In 1992, CEO Jerome Smith founded the business Medpro Pharmaceutica / Cipla Medpro, one of SA’s first generic medicines companies. After strategically aligning the growing business with Cipla, India’s largest pharmaceutical company, Smith proceeded to lead Cipla Medpro to its current standing as third largest local generic medicines company (by volume) and sixth largest pharmaceutical company (by value) (IMS November 2007). The company offers medicines and products across a broad range of categories, including some of today’s most challenging disease categories such as cardio-respiratory, diabetes, oncology, psychiatry and HIV/Aids. Cipla Medpro’s strong relationship with Cipla International has been key to allowing the company to continuously increase market share through the launch of a number of new molecules and establish a reputation for innovation and championing the right to affordable healthcare.